Riskpilot← Back to searchSign inGet full accessARGUS SYN AS
ASActiveOrg 911798786Lille Grensen 5, 0159 OsloMedical specialists activities · NACE 8622Est. 201313 employees
Revenue 2024
NOK 76M
-34% vs 2023
EBITDA margin
18.0%
-49% vs 2023
Equity ratio
37.8%
Financial strength
Net profit 2024
NOK 9,6M
-52% vs 2023
| Revenue | NOK 76M | -34% |
| EBITDA | NOK 13,7M | -49% |
| Net profit | NOK 9,6M | -52% |
| Total assets | NOK 30M | -11% |
| Equity | NOK 11,3M | +4% |
| Employees | 13 | — |
Legal name
ARGUS SYN AS
Org number
911798786
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
10. april 2013
Share capital
NOK 630 000
Employees
13 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-06-30
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Legevirksomhet av enhver art.
Address
Lille Grensen 5, 0159 Oslo
Phone
+4722005950
Email
info@argus-syn.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 44 216 | 50 266 | 56 128 | 114 509 | 75 962 |
| Staff expenses | −8 346 | −8 289 | −13 780 | −25 866 | −18 344 |
| EBITDA | 11 955 | 18 214 | 16 788 | 26 779 | 13 706 |
| Depreciation & amort. | −626 | −346 | −205 | −2 447 | −2 363 |
| EBIT | 11 329 | 17 868 | 16 584 | 24 332 | 11 343 |
| Net financials | −20 | 242 | 286 | 1 085 | 928 |
| Profit before tax | 11 309 | 18 110 | 16 870 | 25 417 | 12 271 |
| Tax | 2 488 | 3 987 | 3 718 | 5 594 | 2 700 |
| Net profit | 8 821 | 14 123 | 13 151 | 19 823 | 9 571 |
| Item | 2019 | 2020 | 2021 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 15 645 | 31 193 | 30 461 | 33 858 | 29 972 |
| Equity | 9 451 | 9 484 | 10 098 | 10 941 | 11 330 |
| Long-term debt | 0 | 0 | 0 | 217 | 327 |
| Short-term debt | 6 194 | 21 710 | 20 363 | 22 700 | 18 315 |
| Total debt | 6 194 | 21 710 | 20 363 | 22 917 | 18 642 |
EBITDA margin
18.0%
This company
15.8%
Market median
+14% vs market
20192024
Equity ratio
37.8%
This company
38.2%
Market median
+1% vs market
20192024
Return on equity
84.5%
This company
18.4%
Market median
+359% vs market
20192024
Net profit margin
12.6%
This company
8.1%
Market median
+56% vs market
20192024
Asset turnover
2.53×
This company
1.12×
Market median
+126% vs market
20192024
Debt / equity
1.65×
This company
0.62×
Market median
-166% vs market
20192024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2023-06-30
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
FM Chief Executive Officer | Chief Executive Officer | 2024 |
| Former (1) | ||
MP Chief Executive Officer | Chief Executive Officer | 2013 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2022 | |
| Former (3) | ||
| Board of Directors | 2020 – 2022 | |
| Chairman | 2022 – 2024 | |
| Chairman | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Capio Norge Holding As
ARGUS SYN AS Board members of ARGUS SYN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Fredrik Mørch-Reiersen | Chief Executive Officer | 0 companies |
| Marianne Pettersen | Chief Executive Officer | 0 companies |
| Per Helge Moe Fagermoen | Chairman | 0 companies |
| Stian Ødegaard Melcher | Board of Directors | 0 companies |
| Per Helge Fagermoen | Chairman | 0 companies |
| Bo Marcus Nord | Chairman | 0 companies |